Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Change in Receivables (2016 - 2025)

Iradimed (IRMD) has disclosed Change in Receivables for 13 consecutive years, with -$191434.0 as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 201.35% to -$191434.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.0 million through Dec 2025, up 271.79% year-over-year, with the annual reading at $3.0 million for FY2025, 271.79% up from the prior year.
  • Change in Receivables for Q4 2025 was -$191434.0 at Iradimed, down from $2.9 million in the prior quarter.
  • The five-year high for Change in Receivables was $2.9 million in Q3 2025, with the low at -$1.8 million in Q2 2025.
  • Average Change in Receivables over 5 years is $461966.0, with a median of $279070.0 recorded in 2021.
  • The sharpest move saw Change in Receivables surged 15386.55% in 2022, then crashed 213.03% in 2023.
  • Over 5 years, Change in Receivables stood at $897395.0 in 2021, then skyrocketed by 197.52% to $2.7 million in 2022, then crashed by 118.68% to -$498857.0 in 2023, then surged by 137.86% to $188885.0 in 2024, then plummeted by 201.35% to -$191434.0 in 2025.
  • According to Business Quant data, Change in Receivables over the past three periods came in at -$191434.0, $2.9 million, and -$1.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.